hydroxyurea has been researched along with Infection in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "1 mM, hydroxyurea (HU) enhances the accumulation of cytosine arabinoside (ara-C) in leukemia cells in vitro." | 9.13 | Sequential oral hydroxyurea and intravenous cytosine arabinoside in refractory childhood acute leukemia: a pediatric oncology group phase 1 study. ( Camitta, B; Dubowy, R; Graham, M; Hakami, N; Kletzel, M; Mahoney, D; Newman, E; Ravindranath, Y, 2008) |
| "1 mM, hydroxyurea (HU) enhances the accumulation of cytosine arabinoside (ara-C) in leukemia cells in vitro." | 5.13 | Sequential oral hydroxyurea and intravenous cytosine arabinoside in refractory childhood acute leukemia: a pediatric oncology group phase 1 study. ( Camitta, B; Dubowy, R; Graham, M; Hakami, N; Kletzel, M; Mahoney, D; Newman, E; Ravindranath, Y, 2008) |
| "A 34% response was obtained in 202 evaluable patients in the terminal phase of chronic granulocytic leukemia using combinations of hydroxyurea, 6-mercaptopurine, and corticosteroids." | 3.66 | Combination chemotherapy for terminal-phase chronic granulocytic leukemia: cancer and leukemia group B studies. ( Cavalli, F; Coleman, M; Glidewell, O; Holland, JF; Kostinas, JE; Pajak, TF; Rai, KR; Silver, RT, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Monus, T | 1 |
| Howell, CM | 1 |
| Couillard, S | 1 |
| Benkerrou, M | 1 |
| Girot, R | 1 |
| Brousse, V | 1 |
| Ferster, A | 1 |
| Bader-Meunier, B | 1 |
| Dubowy, R | 1 |
| Graham, M | 1 |
| Hakami, N | 1 |
| Kletzel, M | 1 |
| Mahoney, D | 1 |
| Newman, E | 1 |
| Ravindranath, Y | 1 |
| Camitta, B | 1 |
| Coleman, M | 1 |
| Silver, RT | 1 |
| Pajak, TF | 1 |
| Cavalli, F | 1 |
| Rai, KR | 1 |
| Kostinas, JE | 1 |
| Glidewell, O | 1 |
| Holland, JF | 1 |
| Yoshida, M | 1 |
| Villalón, L | 1 |
| Odriozola, J | 1 |
| Laraña, JG | 1 |
| Zamora, C | 1 |
| Pérez de Oteyza, J | 1 |
| Jodra, MH | 1 |
| López, J | 1 |
| Herrera, P | 1 |
| Roldán, E | 1 |
| Ramos, ML | 1 |
| Ramos, P | 1 |
| Navarro, JL | 1 |
| Haghbin, M | 1 |
| Tan, CC | 1 |
| Clarkson, BD | 1 |
| Miké, V | 1 |
| Burchenal, JH | 1 |
| Murphy, ML | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Nilotinib Combined by Chemotherapy for Myeloid Blastic Phase of Chronic Myeloid Leukemia or Bcr-abl Positive Acute Myeloid Leukemia[NCT01690065] | Phase 2 | 46 participants (Anticipated) | Interventional | 2012-09-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for hydroxyurea and Infection
| Article | Year |
|---|---|
Current and emerging treatments for sickle cell disease.
Topics: Acute Chest Syndrome; Acute Disease; Analgesics, Opioid; Anemia, Sickle Cell; Anti-Bacterial Agents; | 2019 |
[Management of complications in patients with chronic myelogenous leukemia].
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Graft vs Host Disease; Hematop | 2001 |
1 trial available for hydroxyurea and Infection
| Article | Year |
|---|---|
Sequential oral hydroxyurea and intravenous cytosine arabinoside in refractory childhood acute leukemia: a pediatric oncology group phase 1 study.
Topics: Adolescent; Adult; Child; Child, Preschool; Cytarabine; Humans; Hydroxyurea; Infections; Leukemia; L | 2008 |
4 other studies available for hydroxyurea and Infection
| Article | Year |
|---|---|
Steroid treatment in children with sickle-cell disease.
Topics: Adolescent; Anemia, Sickle Cell; Arthritis; Autoimmune Diseases; Blood Transfusion; Child; Child, Pr | 2007 |
Combination chemotherapy for terminal-phase chronic granulocytic leukemia: cancer and leukemia group B studies.
Topics: Daunorubicin; Dexamethasone; Drug Therapy, Combination; Gastrointestinal Diseases; Hemorrhage; Human | 1980 |
Autologous peripheral blood progenitor cell transplantation with <2 x 10(6) CD34(+)/kg: an analysis of variables concerning mobilisation and engraftment.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell | 2000 |
Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol).
Topics: Administration, Oral; Adolescent; Age Factors; Antineoplastic Agents; Asparaginase; Carmustine; Chem | 1974 |